HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Narain Moorjani Pedro Catarino Stephen Westaby Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moorjani, N. Articles by Westaby, S. Search for Related Content PubMed PubMed Citation Articles by Moorjani, N. Articles by Westaby, S. Related Collections Congestive Heart Failure Molecular biology

Eur J Cardiothorac Surg 2003;24:920-925
© 2003 Elsevier Science NL

A pressure overload model to track the molecular biology of heart failure

^a Department of Cardiothoracic Surgery, Oxford Heart Centre, John Radcliffe Hospital, Oxford OX3 9DY, UK
^b Department of Biological & Medical Research, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia

Received 16 April 2003; received in revised form 28 June 2003; accepted 30 July 2003.

^* Corresponding author. c/o Mr Stephen Westaby's Office, Department of Cardiothoracic Surgery, Oxford Heart Centre, John Radcliffe Hospital, Oxford OX3 9DY, UK. Tel.: +44-1865-220269; fax: +44-1865-220268
e-mail: narain.moorjani{at}doctors.org.uk

Objectives: Pressure overload plays an important role in left ventricular remodelling and the development of heart failure. The underlying molecular mechanisms behind these processes are poorly understood at the myocyte level. To investigate this, we developed an ovine model of pressure overload-induced heart failure, in which serial left ventricular biopsies were obtained. Methods: Adult male sheep were chronically banded with a novel variable aortic constriction device. This was progressively inflated via a subcutaneous port to increase left ventricular afterload. The animals were monitored clinically and echocardiographically. Serial left ventricular endomyocardial biopsies were obtained via the right external carotid artery under fluoroscopic guidance. They were used to measure mRNA expression of the genetic regulators of apoptosis by reverse transcription polymerase chain reaction. In a subset of the animals, once left ventricular failure had been established, the constriction device was deflated to produce unloading of the left ventricle. Results: Ten of the 17 sheep banded developed left ventricular failure. Over the first 3–4 weeks, left ventricular mass index increased acutely (88±18 vs. 44±10 g/m², P<0.01) followed by gradual left ventricular dilatation (diastolic left ventricular internal diameter 4.1±0.7 vs. 3.2±0.3 cm, P<0.01). Ventricular function remained stable until 7–8 weeks postoperatively, when there was significant deterioration (fractional shortening 17±8 vs. 40±8%, P<0.01) associated with clinical heart failure. Expression of the pro-apoptotic genes (bax and Fas) increased significantly following inflation of the constriction device and persisted through the transition to left ventricular failure. Following deflation of the constriction device, myocardial contractility gradually improved over a 3 week period (fractional shortening 32±1 vs. 17±8%). Conclusions: Progressively increasing the afterload on the left ventricle produces a clinical and echocardiographical picture of chronic heart failure. Obtaining myocardial tissue during this transition will allow the molecular correlates of pressure overload-induced heart failure and potential myocardial recovery to be investigated.

Key Words: Ovine model • Heart failure • Left ventricular biopsy • Pressure overload

This article has been cited by other articles:

				T. Hang, Z. Huang, S. Jiang, J. Gong, C. Wang, D. Xie, and H. Ren Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1. Ann. Clin. Lab. Sci., December 1, 2006; 36(1): 88 - 95. [Abstract] [Full Text] [PDF]

				Y.-P. Jiang, L. M. Ballou, Z. Lu, Li Wan, D. J. Kelly, I. S. Cohen, and R. Z. Lin Reversible Heart Failure in G{alpha}q Transgenic Mice J. Biol. Chem., October 6, 2006; 281(40): 29988 - 29992. [Abstract] [Full Text] [PDF]

				N. Moorjani, M. Ahmad, P. Catarino, R. Brittin, D. Trabzuni, F. Al-Mohanna, N. Narula, J. Narula, and S. Westaby Activation of Apoptotic Caspase Cascade During the Transition to Pressure Overload-Induced Heart Failure J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1451 - 1458. [Abstract] [Full Text] [PDF]

				K. Berenji, M. H. Drazner, B. A. Rothermel, and J. A. Hill Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H8 - H16. [Abstract] [Full Text] [PDF]